Group One Trading’s Calithera Biosciences, Inc CALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-660
| Closed | -$2.15K | – | 8363 |
|
|
2022
Q4 | $2.15K | Sell |
660
-1,033
| -61% | -$2.47K | ﹤0.01% | 6636 |
|
|
2022
Q3 | $5K | Sell |
1,693
-1,361
| -45% | -$4.65K | ﹤0.01% | 6880 |
|
|
2022
Q2 | $8K | Buy |
3,054
+534
| +21% | +$2.48K | ﹤0.01% | 6913 |
|
|
2022
Q1 | $20K | Sell |
2,520
-290
| -10% | -$2.96K | ﹤0.01% | 6769 |
|
|
2021
Q4 | $37K | Buy |
2,810
+374
| +15% | +$9.4K | ﹤0.01% | 6558 |
|
|
2021
Q3 | $106K | Sell |
2,436
-394
| -14% | -$17K | ﹤0.01% | 5857 |
|
|
2021
Q2 | $118K | Sell |
2,830
-2,372
| -46% | -$104K | ﹤0.01% | 5800 |
|
|
2021
Q1 | $252K | Sell |
5,202
-1,652
| -24% | -$96.1K | ﹤0.01% | 4781 |
|
|
2020
Q4 | $673K | Buy |
+6,854
| New | +$601K | ﹤0.01% | 3020 |
|
|
2020
Q1 | – | Sell |
-84
| Closed | -$10K | – | 5958 |
|
|
2019
Q4 | $10K | Buy |
+84
| New | +$6.32K | ﹤0.01% | 4614 |
|
|
2019
Q3 | – | Sell |
-212
| Closed | -$17K | – | 5732 |
|
|
2019
Q2 | $17K | Buy |
+212
| New | +$24.1K | ﹤0.01% | 4244 |
|
|
2018
Q1 | – | Sell |
-325
| Closed | -$50.7K | – | 5480 |
|
|
2017
Q4 | $54K | Sell |
325
-977
| -75% | -$250K | ﹤0.01% | 3697 |
|
|
2017
Q3 | $410K | Sell |
1,302
-102
| -7% | -$32.2K | ﹤0.01% | 2237 |
|
|
2017
Q2 | $417K | Buy |
1,404
+1,207
| +613% | +$323K | ﹤0.01% | 2100 |
|
|
2017
Q1 | $45K | Buy |
+197
| New | +$34K | ﹤0.01% | 3478 |
|
|
2016
Q2 | – | Sell |
-45
| Closed | -$4.51K | – | 5059 |
|
|
2016
Q1 | $5K | Buy |
45
+35
| +350% | +$3.97K | ﹤0.01% | 4214 |
|
|
2015
Q4 | $2K | Buy |
+10
| New | +$1.5K | ﹤0.01% | 4555 |
|
Other funds holding CALA
Group One Trading's CALA Position: Q1 2023 in Review
Group One Trading sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 660 shares — an estimated $2.15K sold.
Group One Trading first reported a position in CALA in Q4 2015 and held it in 17 quarters. The position peaked at $673K in Q4 2020. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.
- Group One Trading reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 660 Calithera Biosciences, Inc shares in Q1 2023, an estimated $2.15K.
- Group One Trading first reported a position in Calithera Biosciences, Inc in Q4 2015 and held it in 17 quarters.
- Group One Trading's Calithera Biosciences, Inc position peaked at $673K in Q4 2020.
- 2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.